nach oben

Diabetologia

Erschienen in:

01.03.2008 | Article

The effects of type 1 diabetes on cerebral white matter

verfasst von: K. Weinger, A. M. Jacobson, G. Musen, I. K. Lyoo, C. M. Ryan, D. C. Jimerson, P. F. Renshaw

Erschienen in: Diabetologia | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Aim/hypothesis

Studies investigating the structure, neurophysiology and functional outcomes of white matter among type 1 diabetes patients have given conflicting results. Our aim was to investigate the relationship between type 1 diabetes and white matter hyperintensities.

Method

We assessed white matter integrity (using magnetic resonance imaging), depressive symptoms and neuropsychological function in 114 type 1 diabetes patients and 58 age-matched non-diabetic controls.

Results

Only Fazekas grade 1 and 2 white matter hyperintensities were found among 114 long-duration, relatively young diabetes patients; the severity of lesions did not differ substantially from 58 healthy controls. White matter hyperintensities were not associated with depressive history or with clinical characteristics of diabetes, including retinopathy, severe hypoglycaemia or glycaemia control.

Conclusions/interpretation

Our data do not support an association between diabetes characteristics and white matter hyperintensities among relatively young type 1 diabetes participants.

DCCT (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977–986CrossRef

Ryan CM, Geckle MO, Orchard TJ (2003) Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940–948PubMedCrossRef

Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735PubMedCrossRef

Ferguson SC, Blane A, Perros P et al (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149–156PubMedCrossRef

Ferguson SC, Blane A, Wardlaw J et al (2005) Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28:1431–1437PubMedCrossRef

Brands AM, Kessels RP, Hoogma RP et al (2006) Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800–1806PubMedCrossRef

Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH (1991) Evidence for diabetic encephalopathy. Diabet Med 8:162–167PubMedCrossRef

Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013–1018PubMedCrossRef

Lunetta M, Damanti AR, Fabbri G, Lombardo M, Di Mauro M, Mughini L (1994) Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Invest 17:241–245PubMed

10.

Lobnig BM, Kromeke O, Optenhostert-Porst C, Wolf OT (2006) Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet Med 23:32–39PubMedCrossRef

11.

Yousem DM, Tasman WS, Grossman RI (1991) Proliferative retinopathy: absence of white matter lesions at MR imaging. Radiology 179:229–230PubMed

12.

Musen G, Lyoo IK, Sparks CR et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326–333PubMedCrossRef

13.

Dager SR Friedman SD, Parow A, Demopulos C et al (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450–458CrossRef

14.

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356PubMed

15.

Bae SC, Lyoo IK, Sung YH et al (2006) Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Dependence 81:83–88CrossRef

16.

Lyoo IK, Streeter CC, Ahn KH et al (2004) White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res 131:135–145PubMedCrossRef

17.

Wechsler D (1999) Wechsler Abbreviated Scale of Intelligence manual. The Psychological Corporation, San Antonio, TX

18.

Wechsler D (1997) WAIS-III Wechsler Adult Intelligence Scale, 3rd edn. The Psychological Corporation, San Antonio, TX

19.

Delis DC, Kaplan E, Kramer JH (2001) The Delis–Kaplan Executive Function System: examiner’s manual. The Psychological Corporation, San Antonio, TX

20.

Wechsler D (1997) Wechsler Memory Scale, 3rd edn. The Psychological Corporation, San Antonio, TX

21.

Matthews CG, Klove H (1964) Instruction manual for the Adult Neuropsychology Test Battery. University of Madison Medical School, Madison, WI

22.

Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH (1995) Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251–1255PubMedCrossRef

23.

Oldfield R (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113PubMedCrossRef

24.

Spitzer RL, Williams JB, Gibbon M, First MB (1992) The structured clinical interview for DSM-III-R (SCID). I: History, rationale and description. Arch Gen Psychiatry 49:624–629PubMed

25.

Williams JB, Gibbon M, First MB et al (1992) The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test–retest reliability. Arch Gen Psychiatry 49:630–636PubMed

26.

Hamilton M (2000) Handbook of psychiatric measures. The American Psychiatric Association, Washington, DC

27.

Derogatis LR (1994) SCL-90-R: Symptom Checklist-90-R. Administration, scoring and procedures manual. National Computer Systems, Minneapolis, MN

28.

CCT (1996) Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379–388

29.

Fazekas F (1989) Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 29:164–168PubMed

30.

Fazekas F, Niederkorn K, Schmidt R et al (1988) White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 19:1285–1288PubMed

31.

Silverstone T, McPherson H, Li Q, Doyle T (2003) Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 5:53–57PubMedCrossRef

32.

Schmidt R, Fazekas F, Offenbacher H et al (1993) Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 43:2490–2494PubMed

33.

Schmidt R, Fazekas F, Offenbacher H et al (1991) Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 48:417–420PubMed

34.

Moore PB, Shepherd DJ, Eccleston D et al (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176PubMedCrossRef

35.

Fazekas F, Kleinert R, Offenbacher H et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43:1683–1689PubMed

36.

Thomas AJ, O’Brien JT, Barber R, McMeekin W, Perry R (2003) A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord 76:49–54PubMedCrossRef

37.

Jorm AF, Anstey KJ, Christensen H et al (2005) MRI hyperintensities and depressive symptoms in a community sample of individuals 60–64 years old. Am J Psychiatry 162:699–705PubMedCrossRef

38.

Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ (2005) Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 237:251–257PubMedCrossRef

39.

Novak V, Last D, Alsop DC et al (2006) Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 29:1529–1534PubMedCrossRef

40.

Yetkin FZ, Fischer ME, Papke RA, Haughton VM (1993) Focal hyperintensities in cerebral white matter on MR images of asymptomatic volunteers: correlation with social and medical histories. AJR Am J Roentgenol 161:855–858PubMed

Titel: The effects of type 1 diabetes on cerebral white matter
verfasst von: K. Weinger
A. M. Jacobson
G. Musen
I. K. Lyoo
C. M. Ryan
D. C. Jimerson
P. F. Renshaw
Publikationsdatum: 01.03.2008
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 3/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-007-0904-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Nierenkarzinom | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The effects of type 1 diabetes on cerebral white matter

Abstract

Aim/hypothesis

Method

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin

Springer Medizin

Abstract

Aim/hypothesis

Method

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes

Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study

Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin